-2%
186,95 €
Bisher 190,99 €**
186,95 €
inkl. MwSt.
**Preis der gedruckten Ausgabe (Gebundenes Buch)
Sofort per Download lieferbar
Bisher 190,99 €**
186,95 €
inkl. MwSt.
**Preis der gedruckten Ausgabe (Gebundenes Buch)
Sofort per Download lieferbar

Alle Infos zum eBook verschenken
Als Download kaufen
Bisher 190,99 €**
-2%
186,95 €
inkl. MwSt.
**Preis der gedruckten Ausgabe (Gebundenes Buch)
Sofort per Download lieferbar
Abo Download
9,90 € / Monat*
*Abopreis beinhaltet vier eBooks, die aus der tolino select Titelauswahl im Abo geladen werden können.

inkl. MwSt.
Sofort per Download lieferbar

Einmalig pro Kunde einen Monat kostenlos testen (danach 9,90 € pro Monat), jeden Monat 4 aus 40 Titeln wählen, monatlich kündbar.

Mehr zum tolino select eBook-Abo
Jetzt verschenken
Bisher 190,99 €**
-2%
186,95 €
inkl. MwSt.
**Preis der gedruckten Ausgabe (Gebundenes Buch)
Sofort per Download lieferbar

Alle Infos zum eBook verschenken
93 °P sammeln

  • Format: PDF


Leading interventional cardiologists, including Patrick Serruys, Eric Topol, David Holmes, Thomas Luscher and others provide the gold-standard reference on the treatment of restenosis (coronary artery blockage) for interventional cardiologists. Dr. Serruys, who pioneered the use of drug-eluting stents, and other pioneers in the field cover everything from non-invasive imaging, to eluting stents, to brachytherapy through to the latest molecular biology-based treatments including antisense, stem cells and gene therapy, making this an essential reference for all interventional cardiologists.…mehr

  • Geräte: PC
  • ohne Kopierschutz
  • eBook Hilfe
  • Größe: 22.42MB
Produktbeschreibung
Leading interventional cardiologists, including Patrick Serruys, Eric Topol, David Holmes, Thomas Luscher and others provide the gold-standard reference on the treatment of restenosis (coronary artery blockage) for interventional cardiologists. Dr. Serruys, who pioneered the use of drug-eluting stents, and other pioneers in the field cover everything from non-invasive imaging, to eluting stents, to brachytherapy through to the latest molecular biology-based treatments including antisense, stem cells and gene therapy, making this an essential reference for all interventional cardiologists. TOC:Epidemiology and Pathogenesis of Restenosis.- Clinical Presentation of Restenosis.- Pathologic Anatomy of Restenosis.- The Influence of Shear Stress on Restenosis.- Role of the Immune System in the Pathogenesis of Vascular Proliferative Disease.- Animal Restenosis Models.- From the "Ideal Model" to the "Ideal Study".- The Genomics of Restenosis.- Gene Expression Profiling and Restenosis.- Proteomics and Restenosis.- Contribution of Circulating Progenitor Cells to Vascular Repair and Lesion Formation.- Cell Cycle Regulation in Vascular Proliferative Diseases.- Arterial Remodelling.- The role of eNOS in Vascular Diseases.- The Use of Pressure Gradient Analysis in the Diagnosis of Restenosis.- The Use of Radio Isotopes in the Diagnosis of Vascular Proliferative Disease.- Magnetic resonance imaging for restenosis.- Coronary Imaging with Multislice Spiral Computed Tomography.- Pharmacotherapy of Restenosis.- Brachytherapy.- Pre-clinical Data of Eluting Stents.- Clinical Data of Eluting Stents.- Biodegradable Stents.- Vascular Gene Therapy.- Antisense and ODN Transcription Factors in the Treatment of Vascular Proliferative Disease.- Cell Cycle Approaches to the Treatment of In-stent Restenosis.- Local Gene and Cell Delivery Devices.

Dieser Download kann aus rechtlichen Gründen nur mit Rechnungsadresse in A, B, BG, CY, CZ, D, DK, EW, E, FIN, F, GB, GR, HR, H, IRL, I, LT, L, LR, M, NL, PL, P, R, S, SLO, SK ausgeliefert werden.

  • Produktdetails
  • Verlag: Springer-Verlag GmbH
  • Erscheinungstermin: 13.11.2007
  • Englisch
  • ISBN-13: 9781597450010
  • Artikelnr.: 37342139
Autorenporträt
Henricus J. Duckers, University of Rotterdam, The Netherlands / Patrick W. Serruys, University of Rotterdam, The Netherlands / Elizabeth G. Nabel, National Institutes of Health, Bethesda, MD, USA
Inhaltsangabe
Essentials of Restenosis for the Interventional Cardiologist
Table of Contents:

Part A. Introduction

Henricus J. Duckers
Caroline Cheng
Dennie Tempel
Patrick W. SerruysPart B. Pathophysiology and Diagnosis

Chapter:

1. Epidemiology and Pathogenesis of Restenosis Randolph L. Geary
Alexander W. Clowes

2. Clinical Presentation of Restenosis Ganesh Manoharan
Giedrius Davidavicius
William Wijns

3. Pathologic Anatomy of Restenosis Renu Virmani
Frank D. Kolodgie
Aloke V. Finn
Herman K. Gold

4. The Influence of Shear Stress on Restenosis Attila Thury
Cornelis J. Slager et al.

5. Role of the Immune System in the
Pathogenesis of Vascular Proliferative Disease Jon D. Laman
Burkhard Ludewig

6. Animal Restenosis Models.
From the âEURoeIdeal ModelâEUR? to the âEURoeIdeal StudyâEUR? Arturo G. Touchard
Robert S. Schwartz

Part C. Genetic base of restenosis

Chapter:

7. The Genomics of Restenosis Thomas W. Johnson
Karl R. Karsch

8. Gene Expression Profiling and Restenosis Dietlind Zohlnhà fer
Franz-Josef Neumann

9. Proteomics and Restenosis Santhi K. Ganesh
Elizabeth G. Nabel

10. Contribution of circulating Progenitor Cells to
Vascular Repair and Lesion Formation. Masataka Sata
Kenneth Walsh

11. Cell Cycle Regulation in Vascular
Proliferative Diseases Andrew Wragg
Manfred Boehm

12. Arterial Remodelling Gerard Pasterkamp
Bradley H. Strauss

Dominique de Kleijn

13. The role of eNOS in vascular diseases Alexey Kuroedov
Francesco Cosentino
Felix C. Tanner
Thomas LÃ scher

Part D. Diagnostics of Restenosis

Chapter:

14. The use of pressure gradient analysis in the
diagnosis of restenosis Volker Klaus
Nico N.H.J. Pijls

15. The Use of Radio Isotopes in the Diagnosis
ofVascular Proliferative Disease Giedrius Davidavicius
Ganesh Manoharan
William Wijns

16. Magnetic resonance imaging for restenosis Robert Jan M. van
Geuns
Timo Baks

17. Coronary Imaging with Multislice Spiral
Computed Tomography Koen Nieman

Part E. Therapy of Restenosis

Chapter:

18. Pharmacotherapy of Restenosis Pim J. de Feyter
Georgios Sianos

19. Brachytherapy Ron Waksman

20. Pre-clinical Data of Eluting Stents Antonio Colombo
Alaide Chieffo

21. Clinical Data of Eluting Stents Marco A. Costa
Alexandre Abizaid
Amanda G.M.R. Sousa
Eduardo Sousa

22. Biodegradable stents Takafumi Tsuji
Hideo Tamai

Keiji Igaki

Part F. Biotechnology in the Treatment of Restenosis

Chapter:

23. Vascular Gene Therapy Gurpreet S. Sandhu
Robert D. Simari

24. Antisense and ODN transcription factors
in the treatment of Vascular Proliferative Disease Nicholas Kipshidze
Mykola Tsapenko
George Dangas
Pat Iversen

25. Cell Cycle Approaches to the
Treatment of In-stent Restenosis Elizabeth G. Nabel

26. Local Gene and Cell Delivery Devices Ravish Sachar
Eric J. Topol
Rezensionen
From the reviews: "This is a comprehensive review of the problem of restenosis, from the basic science to clinical management. ... The audience includes interventional cardiology fellows and interventional cardiologists. The book describes the difficulties that cardiologists face trying to prevent and manage restenosis. ... Each chapter includes extensive references. This is a complete, state-of-the-art review of restenosis, covering all aspects of restenosis from pathophysiology to therapeutic management. The authors are leaders in interventional cardiology with extensive clinical experience in the field." (Adriana Maria Rosario, Doody's Review Service, December, 2007) "A multiauthored, comprehensive compendium of virtually all aspects of the restenotic process after balloon- or stent-induced arterial injury. ... The text is written by a blueribbon panel of authors who provide an in-depth coverage of the topics. Many of the clinical chapters offer an excellent historical perspective on the problem of restenotis. ... Recommended Readership: Interventional (clinical and research) cardiologists and interventional fellows." (John F. Bresnahan, Mayo Clinic Proceedings, Vol. 83 (4), April, 2008)